11 Recruiting Metastatic Non Small Cell Lung Cancer Clinical Trials
Explore open interventional and observational research studies actively enrolling participants across the USA. Verify eligibility and contact site coordinators directly.
📍 Find Near Me by DistanceBrowse by State
Top Recruiting Metastatic Non Small Cell Lung Cancer Studies
🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Phase 3 Study of MRTX849 (Adagrasib) vs Docetaxel in Patients With Advanced Non-Small Cell Lung Cancer With KRAS G12C Mutation
📍 Local Institution - 012-898 — Cerritos, California
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations
📍 Ironwood Cancer and Research Center — Chandler, Arizona
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase1 / Phase2 💊 Investigational Drug / Biologic
Safety and Efficacy of Combining APL-101 With Frontline Osimertinib in Patients With EGFR-mutated Metastatic Non-small Cell Lung Cancer (NSCLC)
📍 Washington University School of Medicine — St Louis, Missouri
View Study & Checklist ➔ 🟢 Recruiting Phase2 💊 Investigational Drug / Biologic
Autologous LN-145 in Patients With Metastatic Non-Small-Cell Lung Cancer
📍 Banner Health MD Anderson — Gilbert, Arizona
View Study & Checklist ➔ 🟢 Recruiting Phase1 💊 Investigational Drug / Biologic
MOv19-BBz CAR T Cells in FRa+ Cancers
📍 University of Pennsylvania — Philadelphia, Pennsylvania
View Study & Checklist ➔ 🔵 Active, Not Recruiting Phase3 💊 Investigational Drug / Biologic
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
📍 Southern Cancer Center Pc — Daphne, Alabama
View Study & Checklist ➔